Tacroz/Tacroz Forte Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Adverse Reactions

Adverse reactions with suspected relationship to treatment are listed as follows by system organ class. Frequencies are defined as very common (≥1/10), common (≥1/100 to <1/10) and uncommon (≥1/1,000 to <1/100). Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness. (See table.)

Click on icon to see table/diagram/image

Post-marketing: Cases of malignancies, including cutaneous (i.e. cutaneous T cell lymphomas) and other types of lymphoma, and skin cancers have been reported in patients using Tacrolimus Ointment 0.03% w/w / Tacrolimus Ointment 0.1% w/w.
Paediatric population: Frequency, type and severity of adverse reactions in children are similar to those reported in adults.

View ADR Reporting Link

Tacroz/Tacroz Forte Adverse Reactions

tacrolimus

Manufacturer:

Glenmark

Distributor:

SB Pharma